Why are legal services an important part of Oslo Cancer Cluster? We asked Andrew Wright from Potter Clarkson to explain why they became a member.
Rapporten gir innsikt i en næring som i 2018 omsatte for 142 milliarder kroner.
Oslo Cancer Cluster proudly presents the new members who have joined our organisation during the first quarter of 2019.
Made in Oslo, the first ever Norwegian CAR T cell is now a fact.
A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.
How can the voices of cancer patients be heard when evaluating new methods of treatment?